2017
DOI: 10.1101/218156
|View full text |Cite
Preprint
|
Sign up to set email alerts
|

Easy quantification of template-directed CRISPR/Cas9 editing

Abstract: Template-directed CRISPR/Cas9 editing is a powerful tool for introducing subtle mutations ingenomes. However, the success rate of incorporation of the desired mutations at the target site is difficult to predict and therefore must be empirically determined. Here, we adapted the widely used TIDE method for quantification of templated editing events, including point mutations. The resulting TIDER method is a rapid, cheap and accessible tool for testing and optimization of template-directed genome editing strateg… Show more

Help me understand this report
View published versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

1
73
0

Year Published

2019
2019
2021
2021

Publication Types

Select...
4
1
1

Relationship

1
5

Authors

Journals

citations
Cited by 57 publications
(74 citation statements)
references
References 25 publications
1
73
0
Order By: Relevance
“…Note that TIDE can only detect overall indel frequencies, but not nucleotide substitutions or specifically designed indels. For the latter purpose we developed TIDER (Tracking of Insertions, DEletions, and Recombination events) [14]. This method can estimate the incorporation frequency of template-directed mutations, including point mutations, and distinguish them from a background of additional indels that originate from competing erroneous repair pathways.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…Note that TIDE can only detect overall indel frequencies, but not nucleotide substitutions or specifically designed indels. For the latter purpose we developed TIDER (Tracking of Insertions, DEletions, and Recombination events) [14]. This method can estimate the incorporation frequency of template-directed mutations, including point mutations, and distinguish them from a background of additional indels that originate from competing erroneous repair pathways.…”
Section: Introductionmentioning
confidence: 99%
“…In general, TIDER is able to discriminate "naturally" occurring deletions and insertions from templated "designed" indels. Only in the presence of a small designed deletion (À1, À2) near the expected break site the designed mutation may be underestimated [14]. In case the designed mutation consists of an insertion larger than þ1, TIDER does not consider natural insertions of the same size, because the decomposition becomes less robust.…”
mentioning
confidence: 99%
“…Amplicons were isolated using the PCR cleanup and gel extraction kit (ClonTech, Takara USA, Mountain View, CA) and the nucleotide sequence of amplicons determined by Sanger direct sequencing (GENEWIZ, South Plain eld, NJ). Chromatograms of the sequence reads from the control and experimental groups in each replicate experiment were subjected to online analysis using the TIDE algorithm, https://tide.deskgen.com/ [56,57] and also using the Inference of CRISPR v2 Edits analysis (ICE) software, https://ice.synthego.com/#/ (Synthego Corporation, Redwood City, CA) [58]. Estimates of CRISPR e ciency, insertion-deletion (INDEL)-substitution percentages, and the nucleotide sequence of mutant alleles were obtained using both the TIDE and the ICE platforms ( Fig.…”
Section: Expression Of Cas9 In Bge Cellsmentioning
confidence: 99%
“…The nucleotide sequence of the amplicons was determined by Sanger direct sequencing using the same primers, AIF-F and AIF-R. Both forward and reverse DNA sequencing reads were analyzed for programmed CRISPR/Cas9-catalyzed mutations using two CRISPR editing software packages, the ICE and the TIDE tools [56,57]. Both parse the Sanger sequencing les, either one at a time or as a batch of several technical replicates from the same sample, and identify the sequences complimentary to the gRNA.…”
Section: Transcription Of Cas9 Nuclease In Bge Cellsmentioning
confidence: 99%
“…sequencing or next-generation sequencing (NGS) enable the detection of precise genomic changes without the use of genomic markers (Brinkman et al, 2014;Pinello et al, 2016). However, Sanger-sequencing-based approaches suffer from low sensitivity and precision because of the variable quality of the sequencing reactions and background signals that often affect the sequencing reads (Brinkman et al, 2014(Brinkman et al, , 2018. Furthermore, NGS-dependent detection strategies, while highly sensitive (Clement et al, 2019;Lindsay et al, 2016;Pinello et al, 2016), remain expensive and time consuming, which limits their value for the development of mutant cell lines and animal models and for applications that require a rapid turnaround time, such as the identification of pathogenic variants in certain clinical settings.…”
Section: Introductionmentioning
confidence: 99%